FY17
Assets3.76
Net Worth[●]
Total Debt1.71
RevenueAnnualised basis4.52
EBITDAAnnualised basis1.22
PATAnnualised basis0.70
EBITDA Margin (%)26.99
At a glance
Updated 2026-09-08Dr Lalchandani Labs is an IPO with an issue size of ₹4.20 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹4.20 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets6.02₹ Cr · +221.9% vs prior year
Net Worth3.29₹ Cr
FY16
Assets3.66
Net Worth[●]
Total Debt1.76
RevenueAnnualised basis3.02
EBITDAAnnualised basis0.79
PATAnnualised basis0.32
EBITDA Margin (%)26.16
FY15
Assets1.87
Net Worth[●]
Total Debt1.54
RevenueAnnualised basis1.90
EBITDAAnnualised basis0.51
PATAnnualised basis0.31
EBITDA Margin (%)26.84
31-Jan-18
Assets6.02
Net Worth3.29
Total Debt1.50
RevenueAnnualised basis2.14
EBITDAAnnualised basis0.53
PATAnnualised basis0.24
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Dr Lalchandani Labs IPO | — | 10.00 x | — | — |
| Abh Healthcare IPO | — | 20.69 x | — | — |
| Credent Connect IPO | — | 153.66 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-08.
IPO UPDATE ALERTS
Register for IPO Updates →Track Dr Lalchandani Labs without missing an update
Register for subscription, GMP, allotment and listing notifications.